Clinical trial: A Phase 1/2a, Open-Label, Dose-Escalation Study to Evaluate the Safety and Preliminary Efficacy of TRX319 in Subjects With Primary or Secondary Progressive Multiple Sclerosis

https://clinicaltrials.gov/study/NCT07477639?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20154

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology